Skip to main content

Clostridium Difficile Prevalence and Vancomycin, Fidaxomicin, and Tocilizumab Use

Basic Details
Date Posted
Status
Complete
Medical Product
fidaxomicin
tocilizumab
vancomycin
Health Outcome(s)
clostridium difficile
Description

These reports examine counts and prevalence of one ICD-9-CM diagnosis code for Clostridium difficile as well as prevalent and incident use of generic drugs vancomycin, fidaxomicin, and tocilizumab in the Mini-Sentinel Distributed Database (MSDD). The queries were run against the ICD-9-CM Diagnosis Summary Table and were distributed on July 22, 2013 to 17 Data Partners. These reports include information from 16 Data Partners. 

Deliverables (3)
Mini-Sentinel Summary Table Report: Clostridium Difficile Prevalence Mini-Sentinel Summary Table Report: Vancomycin, Fidaxomicin, and Tocilizumab Prevalent Use Mini-Sentinel Summary Table Report: Vancomycin, Fidaxomicin, and Tocilizumab Incident Use
Additional Details
FDA Center
CDER
Time Period
January 1, 2000 - December 31, 2012
Analysis Type
Summary Table
Data Sources
Mini-Sentinel Distributed Database (MSDD)